J&J’s consumer health unit Kenvue files for U.S. IPO

This post was originally published on this site

https://i-invdn-com.investing.com/trkd-images/LYNXMPEJ030OD_L.jpg

The business houses Band-Aid bandages and Tylenol medicines and generated revenues of $15.1 billion in net sales in 2021, according to the S-1 filing.

The unit has faced nearly 40,000 lawsuits alleging its baby powder and other talc products contained asbestos later linked to mesothelioma and ovarian cancer in women who used it for personal hygiene, which J&J has denied.